Latest Stories
3 Reasons to Avoid BOX and 1 Stock to Buy Instead
Over the past six months, Box’s shares (currently trading at $30.01) have posted a disappointing 10.6% loss, well below the S&P 500’s 11.5% gain. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
KB Home (KBH): Buy, Sell, or Hold Post Q4 Earnings?
Since July 2025, KB Home has been in a holding pattern, posting a small return of 4.1% while floating around $55.41. The stock also fell short of the S&P 500’s 11.5% gain during that period.
3 Reasons to Avoid GLDD and 1 Stock to Buy Instead
Great Lakes Dredge & Dock trades at $12.94 per share and has stayed right on track with the overall market, gaining 14.8% over the last six months. At the same time, the S&P 500 has returned 11.5%.
3 Reasons to Sell MTRX and 1 Stock to Buy Instead
Over the past six months, Matrix Service’s shares (currently trading at $11.74) have posted a disappointing 13.7% loss, well below the S&P 500’s 11.5% gain. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
2 Reasons to Like IRTC (and 1 Not So Much)
Over the past six months, iRhythm has been a great trade, beating the S&P 500 by 27.6%. Its stock price has climbed to $187.29, representing a healthy 39.1% increase. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Hub Group (HUBG): Buy, Sell, or Hold Post Q3 Earnings?
Hub Group has had an impressive run over the past six months as its shares have beaten the S&P 500 by 15.9%. The stock now trades at $45.03, marking a 27.4% gain. This run-up might have investors contemplating their next move.
3 Reasons to Sell ONEW and 1 Stock to Buy Instead
Over the last six months, OneWater’s shares have sunk to $12.56, producing a disappointing 15.8% loss - a stark contrast to the S&P 500’s 11.5% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Halozyme Therapeutics (HALO): Buy, Sell, or Hold Post Q3 Earnings?
Halozyme Therapeutics has had an impressive run over the past six months as its shares have beaten the S&P 500 by 24.3%. The stock now trades at $75.77, marking a 35.8% gain. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
3 Reasons TREE is Risky and 1 Stock to Buy Instead
LendingTree has had an impressive run over the past six months as its shares have beaten the S&P 500 by 27.4%. The stock now trades at $53.29, marking a 38.9% gain. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
3 Reasons to Avoid RTX and 1 Stock to Buy Instead
Since January 2021, the S&P 500 has delivered a total return of 81.5%. But one standout stock has more than doubled the market - over the past five years, RTX has surged 175% to $191.97 per share. Its momentum hasn’t stopped as it’s also gained 32.5% in the last six months thanks to its solid quarterly results, beating the S&P by 21%.